2026 Could Mark Biotech Innovation Turning Point
February 16, 2026·9 days ago·via BioSpace
2026 promises a breakthrough year for American biotech innovation, with FDA's push to ditch outdated animal testing for human-relevant models like organ-on-a-chip boosting drug success rates and slashing failures from flawed trials. AI integrates into regulated drug development, speeding trials, patient matching, and endpoints while proving real efficiency gains.
Related Coverage
Explore More
Obama Breaks Silence on Trump Monkey Clip
Florida Lawmakers Approve Renaming Palm Beach Airport After Trump
E Jean Carroll Gets Trump Valentine's Fundraiser Email
Cassidy Qualifies for Re-Election, Slams Landry Claims
UCLA Opinion: Unengaged Students Face Cognitive Dissonance
LIVE COVERAGE: Person Detained in Guthrie Case
Todd Starnes
American Tourists Caught up in Horrifying Terror Attacks in Mexico
Todd Starnes
MAGA Defends Arizona Diner Under Fire for Feeding ICE Free Burritos
Todd Starnes
Keith Olbermann Calls Men’s Hockey Team ‘Sc*mbags’
Todd Starnes